How does medical device regulation perform in the United States and the European union? A systematic review.
BACKGROUND
Policymakers and regulators in the United States (US) and the European Union (EU) are weighing reforms to their medical device approval and post-market surveillance systems. Data may be available that identify strengths and weakness of the approaches to medical device regulation in these settings.


RESULTS
We performed a systematic review to find empirical studies evaluating medical device regulation in the US or EU. We searched Medline using two nested categories that included medical devices and glossary terms attributable to the US Food and Drug Administration and the EU, following PRISMA guidelines for systematic reviews. We supplemented this search with a review of the US Government Accountability Office online database for reports on US Food and Drug Administration device regulation, consultations with local experts in the field, manual reference mining of selected articles, and Google searches using the same key terms used in the Medline search. We found studies of premarket evaluation and timing (n = 9), studies of device recalls (n = 8), and surveys of device manufacturers (n = 3). These studies provide evidence of quality problems in pre-market submissions in the US, provide conflicting views of device safety based largely on recall data, and relay perceptions of some industry leaders from self-surveys.


CONCLUSIONS
Few studies have quantitatively assessed medical device regulation in either the US or EU. Existing studies of US and EU device approval and post-market evaluation performance suggest that policy reforms are necessary for both systems, including improving classification of devices in the US and promoting transparency and post-market oversight in the EU. Assessment of regulatory performance in both settings is limited by lack of data on post-approval safety outcomes. Changes to these device approval and post-marketing systems must be accompanied by ongoing research to ensure that there is better assessment of what works in either setting.
Harvard Medical School, Boston, Massachusetts, United States of America. dkramer@bidmc.harvard.edu
Daniel B
DB
Kramer
Shuai
S
Xu
Aaron S
AS
Kesselheim
D004864:Equipment and Supplies / Q000706:statistics & numerical data; D005062:European Union; D006801:Humans; D057052:Medical Device Recalls / Q000331:legislation & jurisprudence; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data; D012926:Social Control, Formal; D014481:United States